Status:
NOT_YET_RECRUITING
Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index
Lead Sponsor:
Shanghai Yueyang Integrated Medicine Hospital
Conditions:
Plaque Psoriasis
Eligibility:
All Genders
18-75 years
Brief Summary
Psoriasis (PsO) is a common chronic relapsing inflammatory disease, induced by a combination of genetic and environmental effects, which seriously affects the quality of life of patients.Psoriasis Are...
Detailed Description
High-frequency ultrasound (HFUS) with a center frequency of more than 10 MHz, and a resolution of 16-158 μm. The detailed detection items are epidermal thickness (unit mm), dermal thickness (unit mm),...
Eligibility Criteria
Inclusion
- Patients who meet the medical criteria for plaque psoriasis
- Those who voluntarily participate in this study and sign the informed consent form
Exclusion
- Patients with other types of psoriasis
- Those with other active medical conditions that may affect assessment
- During a severe uncontrollable acute or chronic local or systemic infection
- Those with severe mental illness, cognitive impairment, and incapacity for personal behavior that makes them unsuitable to participate in a clinical study
- Other reasons the investigator considers unsuitable for participation in this study
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06579976
Start Date
September 1 2024
End Date
May 1 2025
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Yueyang Integrated Medicine Hospital
Shanghai, Shanghai Municipality, China, 200080